Ignite Creation Date:
2024-05-06 @ 5:47 PM
Last Modification Date:
2024-10-26 @ 2:35 PM
Study NCT ID:
NCT05432401
Status:
RECRUITING
Last Update Posted:
2022-06-27
First Post:
2022-06-10
Brief Title:
TAA05 Injection in the Treatment of Adult Patients With FLT3-positive RelapsedRefractory Acute Myeloid Leukemia
Sponsor:
PersonGen BioTherapeutics Suzhou Co Ltd
Organization:
PersonGen BioTherapeutics Suzhou Co Ltd
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-06-09
Start Date Type:
ACTUAL
Primary Completion Date:
2023-06-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06-09
Completion Date Type:
ESTIMATED
First Submit Date:
2022-06-10
First Submit QC Date:
June 20 2022
Study First Post Date:
2022-06-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-06-20
Last Update Post Date:
2022-06-27
Last Update Post Date Type:
ACTUAL